• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有临床相关性的经胸除颤能量会导致心肌损伤和功能障碍吗?

Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction?

作者信息

Walcott Gregory P, Killingsworth Cheryl R, Ideker Raymond E

机构信息

Cardiac Rhythm Management Laboratory, Division of Cardiovascular Diseases, Department of Medicine, University of Alabama at Birmingham, Volker Hall B140, 1670 University Blvd., Birmingham, AL 35294, USA.

出版信息

Resuscitation. 2003 Oct;59(1):59-70. doi: 10.1016/s0300-9572(03)00161-8.

DOI:10.1016/s0300-9572(03)00161-8
PMID:14580735
Abstract

Sufficiently strong defibrillation shocks will cause temporary or permanent damage to the heart. Weak defibrillation shocks do not cause any damage to the heart but also do not defibrillate. A relevant and practical question is what range of shock energies is most likely to defibrillate while not causing damage to the heart. This question is most difficult to answer in the pre-hospital defibrillation setting where the patients' size and shape vary, placement of the defibrillation patches vary, and the etiology of their arrhythmia varies. Unlike internal defibrillators, which are tested at implantation, efficacy of an external defibrillator is determined only once, when it is most needed. This review discusses shock damage and dysfunction caused by monophasic waveforms as well as biphasic waveforms. Evidence is presented suggesting that for perfused hearts, the threshold for damage is well above any shock size delivered clinically. For non-perfused hearts, both in humans and animals, evidence is presented that monophasic shocks of up to 5 J/kg do not cause any more cardiac damage/dysfunction than that associated with smaller shocks and that much of this damage is caused by the ischemic period itself rather than the shock. Although many patients can be defibrillated with 150 J (2.2 J/kg) biphasic shocks, some patients may require biphasic shocks up to 360 J (5 J/kg) to be defibrillated. Studies still need to be performed comparing the efficacy and damaging effects of 360 J biphasic shocks to 150 J biphasic shocks. Until those studies are completed, it seems reasonable to use the same 360 J (5 J/kg) energy limit for biphasic shocks as for monophasic shocks.

摘要

足够强的除颤电击会对心脏造成暂时或永久性损伤。较弱的除颤电击不会对心脏造成任何损伤,但也无法实现除颤。一个相关且实际的问题是,何种电击能量范围最有可能实现除颤,同时又不会对心脏造成损伤。在院前除颤环境中,这个问题最难回答,因为患者的体型和形状各异,除颤贴片的放置位置不同,心律失常的病因也不同。与植入时进行测试的体内除颤器不同,体外除颤器的疗效仅在最需要时才确定一次。本综述讨论了单相波形和双相波形引起的电击损伤和功能障碍。有证据表明,对于灌注心脏,损伤阈值远高于临床上传递的任何电击强度。对于人类和动物的非灌注心脏,有证据表明,高达5 J/kg的单相电击造成的心脏损伤/功能障碍并不比小电击更多,而且这种损伤大多是由缺血期本身而非电击造成的。尽管许多患者可以用150 J(2.2 J/kg)的双相电击实现除颤,但有些患者可能需要高达360 J(5 J/kg)的双相电击才能除颤。仍需进行研究,比较360 J双相电击与150 J双相电击的疗效和损伤效果。在这些研究完成之前,对双相电击使用与单相电击相同的360 J(5 J/kg)能量限制似乎是合理的。

相似文献

1
Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction?具有临床相关性的经胸除颤能量会导致心肌损伤和功能障碍吗?
Resuscitation. 2003 Oct;59(1):59-70. doi: 10.1016/s0300-9572(03)00161-8.
2
Biphasic and monophasic shocks for transthoracic defibrillation: a meta analysis of randomised controlled trials.经胸除颤的双相和单相电击:随机对照试验的荟萃分析
Resuscitation. 2003 Jul;58(1):9-16. doi: 10.1016/s0300-9572(03)00077-7.
3
Multicenter comparison of truncated biphasic shocks and standard damped sine wave monophasic shocks for transthoracic ventricular defibrillation. Transthoracic Investigators.
Circulation. 1996 Nov 15;94(10):2507-14. doi: 10.1161/01.cir.94.10.2507.
4
Transthoracic biphasic waveform defibrillation at very high and very low energies: a comparison with monophasic waveforms in an animal model of ventricular fibrillation.极高能量和极低能量经胸双相波除颤:在心室颤动动物模型中与单相波的比较
Resuscitation. 2002 Aug;54(2):183-6. doi: 10.1016/s0300-9572(02)00094-1.
5
Truncated biphasic pulses for transthoracic defibrillation.用于经胸除颤的截断双相脉冲
Circulation. 1995 Mar 15;91(6):1768-74. doi: 10.1161/01.cir.91.6.1768.
6
Biphasic transthoracic defibrillation causes fewer ECG ST-segment changes after shock.
Ann Emerg Med. 1997 Aug;30(2):127-34. doi: 10.1016/s0196-0644(97)70130-6.
7
Transthoracic defibrillation of short-lasting ventricular fibrillation: a randomised trial for comparison of the efficacy of low-energy biphasic rectilinear and monophasic damped sine shocks.短暂性室颤的经胸除颤:一项比较低能量双相直线波与单相阻尼正弦波电击疗效的随机试验
Acta Cardiol. 2002 Oct;57(5):329-34. doi: 10.2143/AC.57.5.2005448.
8
Relation between shock-related myocardial injury and defibrillation efficacy of monophasic and biphasic shocks in a canine model.犬模型中休克相关性心肌损伤与单相和双相电击除颤疗效的关系。
Circulation. 1994 Nov;90(5):2501-9. doi: 10.1161/01.cir.90.5.2501.
9
Biphasic shocks compared with monophasic damped sine wave shocks for direct ventricular defibrillation during open heart surgery.在心脏直视手术期间,双相电击与单相阻尼正弦波电击用于直接心室除颤的比较。
Anesthesiology. 2003 May;98(5):1063-9. doi: 10.1097/00000542-200305000-00007.
10
Comparison of a novel rectilinear biphasic waveform with a damped sine wave monophasic waveform for transthoracic ventricular defibrillation. ZOLL Investigators.
J Am Coll Cardiol. 1999 Nov 1;34(5):1595-601. doi: 10.1016/s0735-1097(99)00363-0.

引用本文的文献

1
Amplitude spectral area of ventricular fibrillation and defibrillation success at low energy in out-of-hospital cardiac arrest.室颤振幅谱面积与院外心脏骤停低能量除颤成功。
Intern Emerg Med. 2023 Nov;18(8):2397-2405. doi: 10.1007/s11739-023-03386-6. Epub 2023 Aug 9.
2
The first case series analysis on efficacy of esmolol injection for in-hospital cardiac arrest patients with refractory shockable rhythms in China.中国首个关于艾司洛尔注射液对难治性可电击心律的院内心脏骤停患者疗效的病例系列分析。
Front Pharmacol. 2022 Sep 30;13:930245. doi: 10.3389/fphar.2022.930245. eCollection 2022.
3
Non-monotonous dose response function of the termination of spiral wave chaos.
螺旋波混沌终止的非单调剂量反应函数。
Sci Rep. 2022 Jul 14;12(1):12043. doi: 10.1038/s41598-022-16068-8.
4
Personalized Low-Energy Defibrillation Through Feedback Based Resynchronization Therapy.通过基于反馈的再同步治疗实现个性化低能量除颤
Comput Cardiol (2010). 2020 Sep;2020. doi: 10.22489/cinc.2020.471. Epub 2021 Feb 10.
5
A Randomized Comparison of Delivered Energy in Cardioversion of Atrial Fibrillation: Biphasic Truncated Exponential Versus Pulsed Biphasic Waveforms.心房颤动电复律中输送能量的随机比较:双相截断指数波形与脉冲双相波形
Diagnostics (Basel). 2021 Jun 17;11(6):1107. doi: 10.3390/diagnostics11061107.
6
Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option.心房颤动的当前药物治疗策略以及作为一种新兴的新型治疗选择的TASK-1抑制作用。
Front Pharmacol. 2021 Mar 4;12:638445. doi: 10.3389/fphar.2021.638445. eCollection 2021.
7
External Cardioversion-Defibrillation with Pushing Down on the Chest Wall to Increase the Success Rate in Obese Patients.按压胸壁增加肥胖患者体外除颤转复成功率。
Am J Case Rep. 2020 Nov 16;21:e927009. doi: 10.12659/AJCR.927009.
8
Phase Entrainment of Induced Ventricular Fibrillation: A Human Feasibility and Proof of Concept Study.诱发性心室颤动的相位同步:一项人体可行性及概念验证研究。
J Atr Fibrillation. 2019 Dec 31;12(4):2217. doi: 10.4022/jafib.2217. eCollection 2019 Dec.
9
High-energy external defibrillation and transcutaneous pacing during MRI: feasibility and safety.磁共振成像期间高能体外除颤和经皮起搏:可行性和安全性。
J Cardiovasc Magn Reson. 2019 Aug 5;21(1):47. doi: 10.1186/s12968-019-0558-z.
10
Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis.心房颤动与植入式心脏复律除颤器患者的全因死亡率升高相关:系统评价和荟萃分析。
J Am Heart Assoc. 2018 Nov 20;7(22):e010156. doi: 10.1161/JAHA.118.010156.